Expression of CD44 variant exons 8-10 in gastric cancer

被引:35
|
作者
Yamaguchi, A [1 ]
Saito, M [1 ]
Goi, T [1 ]
Iida, A [1 ]
Takeuchi, K [1 ]
Hirose, K [1 ]
Nakagawara, G [1 ]
Urano, T [1 ]
Furukawa, K [1 ]
Shiku, H [1 ]
机构
[1] NAGASAKI UNIV,SCH MED,DEPT ONCOL,NAGASAKI 852,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1995年 / 86卷 / 12期
关键词
gastric cancer; CD44 variant exons 8-10; monoclonal antibody 44-1V; hematogenous metastasis; peritoneal dissemination;
D O I
10.1111/j.1349-7006.1995.tb03310.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of CD44 variant containing variant exons 8-10 product (CD44v8-10) was studied by western blot analysis and immunohistochemistry in gastric cancers using a monoclonal antibody, 44-1V. On western blots, a single band of 130 kD was recognized in stomach cancer cell lines. CD44v-810 expression, with reactivity localized in the cell membrane, was found in 65 (33.5%) of the 194 advanced gastric cancers. There was no correlation between CD44v8-10 immunoreactivity and serosal, lymphatic, or lymph node invasion. However, there was significant correlation with CD44v8-10 immunoreactivity and venous invasion, CD44v8-10-positive cancers were more frequently associated with hematogenous metastasis than those which were immunonegative, There was an inverse association between CD44v8-10 immunoreactivity and peritoneal dissemination, especially in diffuse type adenocarcinomas, These observations indicate that CD44v8-10 may play a role in the metastasis of gastric cancer.
引用
收藏
页码:1166 / 1171
页数:6
相关论文
共 50 条
  • [1] EXPRESSION OF CD44 VARIANT EXONS 8-10 IN COLORECTAL-CANCER AND ITS RELATIONSHIP TO METASTASIS
    TAKEUCHI, K
    YAMAGUCHI, A
    URANO, T
    GOI, T
    NAKAGAWARA, G
    SHIKU, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (03): : 292 - 297
  • [2] Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer
    Yamaguchi, A
    Goi, T
    Taguchi, S
    Ohtaki, N
    Seki, K
    Hirose, K
    Nakagawara, G
    Urano, T
    Furukawa, K
    [J]. JOURNAL OF GASTROENTEROLOGY, 1998, 33 (03) : 349 - 353
  • [3] Soluble protein encoded by CD44 variant exons 8-10 in the serum of patients with colorectal cancer
    Goi, T
    Yamaguchi, A
    Seki, K
    Nakagawara, G
    Urano, T
    Shiku, H
    Furukawa, K
    [J]. BRITISH JOURNAL OF SURGERY, 1997, 84 (10) : 1452 - 1453
  • [4] CD44 with variant exons 8-10 in colorectal tumors: Expression analysis by a variant exon 9-specific monoclonal antibody
    Goi, T
    Yamaguchi, A
    Takeuchi, K
    Nakagawa, G
    Yamashiro, S
    Furukawa, K
    Urano, T
    Shiku, H
    Furukawa, K
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (04) : 657 - 662
  • [5] EXPRESSION OF VARIANT CD44 EXONS IN COLORECTAL NEOPLASIAS
    ORZECHOWSKI, HD
    BECKENBACH, C
    STALLMACH, A
    RIECKEN, EO
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A437 - A437
  • [6] Expression of CD44 variant exons by fibroblasts.
    Desai, H
    [J]. JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1142 - 1142
  • [7] Clinical significance of serum levels of CD44 variant exons 8–10 protein in colorectal cancer
    Akio Yamaguchi
    Takanori Goi
    Seiichi Taguchi
    Norio Ohtaki
    Kenichiro Seki
    Kazuo Hirose
    Gizo Nakagawara
    Takeshi Urano
    Koichi Furukawa
    [J]. Journal of Gastroenterology, 1998, 33 : 349 - 353
  • [8] Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients
    Yamaguchi, A
    Urano, T
    Goi, T
    Saito, M
    Takeuchi, K
    Hirose, K
    Nakagawara, G
    Shiku, H
    Furukawa, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1122 - 1127
  • [9] Expression of CD44 variant exons by normal oral epithelia
    Oliveira, DT
    Odell, EW
    [J]. ORAL ONCOLOGY, 1997, 33 (04) : 260 - 262
  • [10] Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer
    Yamaguchi, A
    Zhang, M
    Goi, T
    Fujita, T
    Niimoto, S
    Katayama, K
    Hirose, K
    [J]. ONCOLOGY REPORTS, 2000, 7 (03) : 541 - 544